4//SEC Filing
Greenspan Ira Scott 4
Accession 0001104659-21-027147
CIK 0001772028other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 7:46 AM ET
Size
7.6 KB
Accession
0001104659-21-027147
Insider Transaction Report
Form 4
Greenspan Ira Scott
Director
Transactions
- Purchase
Common Stock, par value $0.001
2021-02-23$9.58/sh+200$1,916→ 80,675 total - Purchase
Common Stock, par value $0.001
2021-02-23$9.66/sh+1,300$12,558→ 6,650 total(indirect: HCFP)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.36 to $9.95 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.50 to $9.90 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4
- [F3]Mr. Greenspan is deemed to have shared voting and dispositive power over HCFP-held securities. Mr. Greenspan disclaims beneficial ownership of shares by this entity, except to the extent of his proportionate pecuniary interest therein.
Documents
Issuer
Scopus BioPharma Inc.
CIK 0001772028
Entity typeother
Related Parties
1- filerCIK 0001449211
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 7:46 AM ET
- Size
- 7.6 KB